Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,677 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neutralizing antibodies in multiple sclerosis patients treated with 375 micrograms interferon-beta-1b.
Durelli L, Barbero P, Cucci A, Ferrero B, Ricci A, Contessa G, De Mercanti S, Ripellino P, Lapuma D, Viglietta E, Bergui M, Versino E, Clerico M; OPTIMS Trial NAb Sub-Study Group. Durelli L, et al. Among authors: ricci a. Expert Opin Biol Ther. 2009 Apr;9(4):387-97. doi: 10.1517/14712590902762781. Expert Opin Biol Ther. 2009. PMID: 19278300 Clinical Trial.
Interferon-beta dose and efficacy: the OPTIMS study.
Durelli L, Oggero A, Verdun E, Barbero P, Pipieri A, Isoardo G, Ricci A, Clerico M, Bradac G, Bergamasco B, Bergui M. Durelli L, et al. Among authors: ricci a. Neurol Sci. 2001 Apr;22(2):201-3. doi: 10.1007/s100720170024. Neurol Sci. 2001. PMID: 11603627
Autoimmune events during interferon beta-1b treatment for multiple sclerosis.
Durelli L, Ferrero B, Oggero A, Verdun E, Bongioanni MR, Gentile E, Isoardo GL, Ricci A, Rota E, Bergamasco B, Durazzo M, Saracco G, Biava MA, Brossa PC, Giorda L, Pagni R, Aimo G. Durelli L, et al. Among authors: ricci a. J Neurol Sci. 1999 Jan 1;162(1):74-83. doi: 10.1016/s0022-510x(98)00299-8. J Neurol Sci. 1999. PMID: 10064173 Clinical Trial.
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with Nab.
Barbero P, Bergui M, Versino E, Ricci A, Zhong JJ, Ferrero B, Clerico M, Pipieri A, Verdun E, Giordano L, Durelli L; INCOMIN Trial Study Group. Barbero P, et al. Among authors: ricci a. Mult Scler. 2006 Feb;12(1):72-6. doi: 10.1191/135248506ms1247oa. Mult Scler. 2006. PMID: 16459722 Clinical Trial.
Monitoring circulating tumor DNA liquid biopsy in stage III BRAF-mutant melanoma patients undergoing adjuvant treatment.
Marchisio S, Ricci AA, Roccuzzo G, Bongiovanni E, Ortolan E, Bertero L, Berrino E, Pala V, Ponti R, Fava P, Osella-Abate S, Deaglio S, Marchiò C, Sapino A, Senetta R, Funaro A, Ribero S, Quaglino P, Cassoni P. Marchisio S, et al. Among authors: ricci aa. J Transl Med. 2024 Nov 28;22(1):1074. doi: 10.1186/s12967-024-05783-7. J Transl Med. 2024. PMID: 39609824 Free PMC article.
1,677 results